Company Archives - CVRx

1
2
3
4
5
6
7

See the Poster Here: Symptomatic Endpoint Responder Rates to BAROSTIM THERAPY

See the Poster Here: Quality of Life Response to BAROSTIM THERAPY

Does Neuromodulation Using Baroreflex Activation Therapy (BAT) have Potential Application in HFpEF?

News release: CVRx® Completes Enrollment of the BeAT-HF Phase III Randomized Clinical Trial, Continues to collect Morbidity and Mortality Outcomes

News release: CVRx® Raises $50 Million in New Equity Financing

1
2
3
4
5
6
7

1 of 7 pages